Intravitreal Injection of anti-TNF (Remicade) for Wet AMD

June 7, 2009

Investigators (May AJO) demonstrated excellent response to intravitreal injection of anti-TNF (Remicade) for neovascular age-related macular degeneration. This was a small study of three patients who failed traditional anti-VEGF injections. Clearly, TNF factors are also involved in the cascade of events that lead to wet ARMD. Let’s hope some progress can finally be made for the dry ARMD.




Jump down to form below to submit your own comments

Comments are closed.